Endothelial Function in Hispanic Children/Adolescents at Risk for Type 2 Diabetes
1 other identifier
observational
38
0 countries
N/A
Brief Summary
Type 2 diabetes is now more frequent in children/adolescents, especially in those from minority populations, including Hispanic Americans (HA). Diabetes and the pre-diabetes state markedly increase the risk of cardiovascular disease. Endothelial dysfunction is seen in the earliest stages of atherogenesis, which ultimately leads to cardiovascular disease. The main aim of this study is to evaluate the endothelial function in HA children/adolescents who are at risk for developing type 2 diabetes (obese children/adolescents from the Hispanic population). The investigators' hypothesis is that endothelial dysfunction is present in this population and that it is associated with metabolic abnormalities linked to the insulin resistance syndrome. The investigators will study 2 groups of 15 individuals each, age 10-18 years. Group 1 will consist of obese (body mass index greater than 85th percentile for age and sex) Hispanic American children/adolescents and group 2 will consist of healthy, non-overweight (body mass index between the 25th and 50 th percentile for age and sex) Hispanic American children/adolescents. The study will be carried out at the Joslin Diabetes Center. During the first day, participants will have a medical history and full physical examination, a standard OGTT and measurement of blood cell count, plasma glucose, insulin, lipids, HbA1c, BUN, creatinine, electrolytes, estradiol, testosterone, free fatty acids, CRP, endothelial markers, urinary microalbumin and hCG, if appropriate. An OGTT will be performed in order to rule out IGT or Diabetes. Estimations of insulin secretion and insulin sensitivity will be assessed using the homeostasis model assessment (HOMA). In the second day, the body composition and the brachial artery vasodilatory response to hyperemia will be assessed. Those found with diabetes will be tested for GAD-65 and IA2. The investigators' hypothesis is that Hispanic American children/adolescents at risk for type 2 diabetes have impaired endothelial function and vascular reactivity that are associated with the degree of insulin resistance and its metabolic abnormalities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2001
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2001
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2012
CompletedFirst Submitted
Initial submission to the registry
August 19, 2013
CompletedFirst Posted
Study publicly available on registry
August 21, 2013
CompletedAugust 21, 2013
August 1, 2013
9 years
August 19, 2013
August 20, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Plasma levels of markers of endothelial activation and vascular inflammation
cross sectional study - one time evaluation
Study Arms (2)
1
Overweight Hispanic children/adolescents
2
Lean Hispanic children/adolescents
Eligibility Criteria
Hispanic children/adolescents
You may qualify if:
- Group 1:
- Age between 10-18 years;
- Hispanic (we will consider a subject being Hispanic if both parents are reported as Hispanics when asked the following question: "What ethnic group do you consider that you belong to?");
- No history of type 2 diabetes in any first-degree relative;
- Body mass index between the 25th and 50th percentile for age and sex
- Not have participated in any exercise program for the 6 months prior to the beginning of the study.
- Group 2:
- Age between 10-18 years;
- Hispanic (same criteria as above);
- Body mass index greater than the 85th percentile for age and sex;
- Not have participated in any exercise program for the 6 months prior to the beginning of the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Biospecimen
plasma samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Enrique Caballero, MD
Joslin Diabetes Center
Study Design
- Study Type
- observational
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Investigator/Director Latino Diabetes Initiative
Study Record Dates
First Submitted
August 19, 2013
First Posted
August 21, 2013
Study Start
May 1, 2001
Primary Completion
May 1, 2010
Study Completion
February 1, 2012
Last Updated
August 21, 2013
Record last verified: 2013-08